For further analysis of breast cancer, rs12945597 in TOP3A, rs401549, and rs2532105 in BLM were selected, as well as rs1563634 in TOP3A, which showed similar non-significant protective effects in all three cancer forms for the variant homozygous carriers. This evidence concerns the gene BLM and breast carcinoma.